SCRI Mark H. Zangmeister Center — Columbus, Ohio

SCRI Mark H. Zangmeister Center is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI Mark H. Zangmeister Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer, Advanced Unresectable or Metastatic Solid Malignancy.

Sponsors: Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Mark H. Zangmeister Center?

SCRI Mark H. Zangmeister Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Mark H. Zangmeister Center conducted?

SCRI Mark H. Zangmeister Center has 2 clinical trials on record, with 1 currently active. Their work covers Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer, Advanced Unresectable or Metastatic Solid Malignancy.

Is SCRI Mark H. Zangmeister Center accredited by Crixeo Health?

SCRI Mark H. Zangmeister Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Mark H. Zangmeister Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.